The FDA-approved drug Auranofin has a dual inhibitory effect on SARS-CoV-2 entry and NF-κB signaling.
Laplantine E, Chable-Bessia C, Oudin A, Swain J, Soria A, Merida P, Gourdelier M, Mestiri S, Besseghe I, Bremaud E, Neyret A, Lyonnais S, Favard C, Benaroch P, Hubert M, Schwartz O, Guerin M, Danckaert A, Del Nery E, Muriaux D, Weil R.
Laplantine E, et al. Among authors: neyret a.
iScience. 2022 Oct 21;25(10):105066. doi: 10.1016/j.isci.2022.105066. Epub 2022 Sep 3.
iScience. 2022.
PMID: 36093378
Free PMC article.